Acelot is a development stage biopharmaceutical company focused on therapies for Alzheimer’s Disease and central nervous system disorders. Our revolutionary JPS technology allows us to develop on-target therapies with a high degree of therapeutic predictability.
At the core of Acelot’s technology is a novel and unique computer algorithm, “JPS”, that has been developed at the University of California and was validated in a variety of studies. JPS allows the identification of latent pharmacophore information and can be used for rapid lead identification and optimization even for drug development projects without clear target information or crystallography data. Furthermore, JPS is useful for screening against undesired pathways and targets to minimize the risk of side-effects.
Lorem ipsum dolor sit amet, consectetur adipiscinr dolor sit amet.
Lorem ipsum dolordolor sit amet sit amet, consectetur adipiscinr
Lorem dolor sit ametipsum dolor sit amet, consectetur adipiscinr
Lorem ipsum dolor sit amet, ullamcorper tellus Cras.
Lorem ipsum dolor sit amet, dolor sit amet consectetur adipiscinr sed.
Lorem ipsum dolor sit amet, dolor sit amet consectetur adipiscinr
Lorem ipsum dolor sit dolor sit amet amet, consectetur adipiscinr
Lorem ipsum dolor sit amet dolor sit amet, ullamcorper tellus Cras.
Aliquam et varius orci, ut ornare justo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque augue metus, blandit vel nibh sed, sollicitudin placerat quam. Quisque id scelerisque nibh. Phasellus in orci et felis tristique finibus non quis erat. Quisque nec congue nunc, sagittis aliquet orci. Quisque pulvinar feugiat sodales. Nam fermentum tempus odio sed euismod Quisque pulvinar feugiat sodales. Nam fermentum tempus odio sed euismod.
Aliquam et varius orci, ut ornare justo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque augue metus, blandit vel nibh sed, sollicitudin placerat quam. Quisque id scelerisque nibh. Phasellus in orci et felis tristique finibus non quis erat. Quisque nec congue nunc, sagittis aliquet orci. Quisque pulvinar feugiat sodales. Nam fermentum tempus odio sed euismod Quisque pulvinar feugiat sodales. Nam fermentum tempus odio sed euismod.
The founder of Acelot, Prof. Singh, has authored over 140 scientific papers in the areas of bioinformatics, data mining, databases, and…
Read MoreSorry, photo gallery is empty.
Acelot is a development stage biopharmaceutical company focused on therapies for Alzheimer’s Disease and central nervous system disorders. Our revolutionary JPS technology allows us to develop on-target therapies with a high degree of therapeutic predictability.
Acelot's drug discovery pipeline comprises several compound families for Alzheimer's disease. These compounds span a variety of mechanisms-of-action and have been validated in a number of in-vitro assays to date.
5385 Hollister Ave, Suite 111, Santa Barbara, CA 93111, U.S.A.